1Szalardy L,Zadori D,Simu M,et al.Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis osteopontin as a potential marker of clinical severity[J].J Neurol Sci,2013,331:38-42.
2Anderson JM,Hampton DW,Patani R,et al.Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis[J].Brain,2008,7(131):1736-1748.
3Hien T,Sanchez T,Brody L,et al.Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice[J].Neuropathol Exp Neurol,2012,71(2):16-29.
4Frost B,Hemberg M,Lewis J,et al.Tau promotes neurodegeneration through global chromatin relaxation[J].Nat Neurosci,2014,17(3):57-66.
5Liu Y,Rodriguez L,Wolfe MS.Template-directed synthesis of a small molecule-antisense conjugate targeting an m RNA structure[J].Bioorg Chem,2014,54(3):7-11.
6Martin L,Latypova X,Wilson CM,et al.Tau protein kinases:involvement in Alzheimer′s disease[J].Ageing Res Rev,2013,12(1):289-309.
8Hernández F,Gómez de Barreda E,Fuster-Matanzo A,et al.GSK3:a possible link between beta amyloid peptide and tau protein[J].Exp Neurol,2010,223(2):322-325.
9De Calignon A,Polydoro M,Suárez-Calvet M,et al.Propagation of tau pathology in a model of early Alzheimer′s disease[J].Neuron,2012,73(4):685-697.
10Liu L,Drouet V,Wu JW,et al.Trans-synaptie spread of tau pathology in vivo[J].PLo S One,2012,7(2):31-32.
